Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients

Lixisenatide in type 1 diabetes: A randomised control trial of the effect of lixisenatide on post‐meal glucose excursions and glucagon in type 1 diabetes patients

Aims The GLP1 agonist lixisenatide is glucagonostatic and reduces post‐prandial blood glucose (PPBG) in type 2 diabetes. This study investigates its impact in type 1 diabetes (T1D). <br></br> Methods In a blinded, crossover trial, 25 patients with T1D were randomised to 4 weeks adjunctiv...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Ballav, C, Dhere, A, Kennedy, I, Agbaje, O, Owen, K, White, S, Franklin, R, Hartman, B, Holst, J, Holman, J
Format:	Journal article
Język:	English
Wydane:	Wiley 2020

Podobne zapisy

PROLONGED INFUSION OF GLUCAGON-LIKE PEPTIDE-1 IN TYPE-2 DIABETES NORMALIZES INSULIN-RESPONSE TO GLUCOSE
od: Gribble, F, i wsp.
Wydane: (1995)

Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes.
od: Zhang, Q, i wsp.
Wydane: (2013)

Glucagon like peptide-1 similarly amplifies insulin secretion in late-onset type 1 and type 2 diabetes
od: Maksoud, H, i wsp.
Wydane: (1999)

Arginine-vasopressin mediates counter-regulatory glucagon release and is diminished in type 1 diabetes
od: Kim, A, i wsp.
Wydane: (2021)

Type 1 and type 2 diabetes-chalk and cheese?
od: Owen, K, i wsp.
Wydane: (2009)

Predicting post one-year durability of glucose-lowering monotherapies in patients with new-onset type 2 diabetes
od: Agbaje, O, i wsp.
Wydane: (2017)

NON-SULFONYLUREA A4166 STIMULATES INSULIN IN TYPE-2 DIABETES AND REDUCES POSTPRANDIAL GLUCOSE EXCURSION BY 64-PERCENT
od: Levy, J, i wsp.
Wydane: (1995)

Risk of microvascular complications over 30 years in latent autoimmune diabetes of adults compared with type 2 diabetes
od: Maddaloni, E, i wsp.
Wydane: (2019)

[Type 1 diabetes in children].
od: Ali, K, i wsp.
Wydane: (2011)

Type 1 diabetes in children
od: Ali, K, i wsp.
Wydane: (2011)

Type 1 diabetes in children.
od: Ali, K, i wsp.
Wydane: (2011)

Follow-up of Intensive Glucose Control in Type 2 Diabetes Reply
od: Holman, R, i wsp.
Wydane: (2009)

Improving glucose control and cardiovascular risk in general practice Type 2 diabetes.
od: Potts, N, i wsp.
Wydane: (2003)

Optimizing blood glucose control in type 2 diabetes: an approach based on fasting blood glucose measurements.
od: Holman, R, i wsp.
Wydane: (1988)

Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes.
od: Nielsen, L, i wsp.
Wydane: (2007)

Type 1 diabetes: a relatively unknown sibling of type 2 diabetes
od: Ahmad Mahfuz, Gazali
Wydane: (2021)

Effect of type 1 diabetes and type 2 diabetes on the risk of venous thromboembolism
od: Hinton, W, i wsp.
Wydane: (2020)

Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.
od: Holman, R, i wsp.
Wydane: (2014)

Intensive glucose control and macrovascular outcomes in type 2 diabetes.
od: Turnbull, F, i wsp.
Wydane: (2009)

Effects of meals differing in glycemic index on postprandial glucose and insulin levels in individuals with and without type 2 diabetes mellitus
od: Lau, Zhi Ch'ng
Wydane: (2021)

Late onset type 1 diabetes.
od: Lasserson, D, i wsp.
Wydane: (2012)

Late onset type 1 diabetes
od: Lasserson, D, i wsp.
Wydane: (2012)

Type 1 diabetes: The theme for this edition
od: Narendran, P, i wsp.
Wydane: (2009)

Late onset type 1 diabetes.
od: Lasserson, D, i wsp.
Wydane: (2012)

Causal mechanisms in type 1 diabetes
od: Rubio Garcia, A
Wydane: (2022)

10-year follow-up of intensive glucose control in type 2 diabetes.
od: Holman, R, i wsp.
Wydane: (2008)

Development of type 1 diabetes mellitus blood glucose level simulation mobile application
od: Mohamad Akbar, Asyraf Aiman
Wydane: (2020)

Glucose in glucagon release.
od: Rorsman, P, i wsp.
Wydane: (1990)

Modelling incremental benefits on complications rates when targeting lower HbA1c levels in people with Type 2 diabetes and cardiovascular disease
od: Mostafa, SA, i wsp.
Wydane: (2017)

Postprandial glucose and its role in type 2 diabetes.
od: Davidson, J, i wsp.
Wydane: (2006)

Postprandial glucose and its role in type 2 diabetes.
od: Davidson, J, i wsp.
Wydane: (2006)

Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes--Authors' reply.
od: Holman, R, i wsp.
Wydane: (2014)

Treating young adults with type 2 diabetes or monogenic diabetes
od: Owen, K
Wydane: (2016)

Genetics of type 2 diabetes.
od: Owen, K, i wsp.
Wydane: (2007)

Self-care behaviour and blood glucose control in young adults with type 1 diabetes mellitus.
od: Peveler, R, i wsp.
Wydane: (1993)

Insulin therapy in type II diabetes.
od: Holman, R, i wsp.
Wydane: (1995)

An updated review of type 1 diabetes in Malaysia
od: Ahmad Mahfuz, Gazali
Wydane: (2022)

An updated review of type 1 diabetes in Malaysia
od: MN, Nurhanani, i wsp.
Wydane: (2022)

Verification of type 1 diabetes mellitus model
od: Sri Vathsavai Neelima
Wydane: (2014)

Dynamic modeling of type 1 diabetic metabolism
od: Jivesh Ramduny
Wydane: (2015)